Portal:CPTAC/Hallmark/Proliferative
From WikiPathways
(Difference between revisions)
| Line 7: | Line 7: | ||
*[[Pathway:WP4205]] MET in type 1 papillary renal cell carcinoma | *[[Pathway:WP4205]] MET in type 1 papillary renal cell carcinoma | ||
*[[Pathway:WP4255]] Non-small cell lung cancer | *[[Pathway:WP4255]] Non-small cell lung cancer | ||
| + | *[[Pathway:WP4263]] Pancreatic adenocarcinoma pathway | ||
Revision as of 00:50, 28 September 2018
- Pathway:WP3972 PDGFR-beta pathway
- Pathway:WP673 ErbB Signaling Pathway
- Pathway:WP581 EPO Receptor Signaling
- Pathway:WP382 MAPK Signaling Pathway
- Pathway:WP4223 Ras Signaling
- Pathway:WP2828 Bladder Cancer
- Pathway:WP4205 MET in type 1 papillary renal cell carcinoma
- Pathway:WP4255 Non-small cell lung cancer
- Pathway:WP4263 Pancreatic adenocarcinoma pathway
